Companies · Other Health Care

Mardil, Inc.

PLYMOUTH · Other Health Care

Diligence memoA one-page analyst read on Mardil, Inc. — recommendation, valuation, rhythm, risks.
$12.8M
Total raised · real
5
Rounds
0.2×
Latest step-up
Top 22%
Sector rank · raised
Series A
Latest stage · inferred · Thu Nov 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Mardil, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.15× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era.
Dormant
  • Last raise 7.6 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Mardil, Inc. is one of 5376 Other Health Care companies tracked from PLYMOUTH. By capital raised it ranks in the upper tier (ahead of 79% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2018-11-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeed · 2010-07-30 Raised $1.6M (real) Modeled valuation $38M (est)$1.6M$38MSeed2010Seed · 2010-07-30 Raised $2.8M (real) Modeled valuation $69M (est)$2.8M$69MSeed2010Series A · 2013-01-29 Raised $4.3M (real) Modeled valuation $86M (est)$4.3M$86MSeries A2013Series A · 2013-12-16 Raised $500K (real) Modeled valuation $10M (est)$500K$10MSeries A2013Series A · 2016-12-21 Raised $4.3M (real) Modeled valuation $87M (est)$4.3M$87MSeries A2016Series A · 2018-11-15 Raised $903K (real) Modeled valuation $18M (est)$903K$18MSeries A2018+$2.8M+$4.3M+$500K+$4.3M+$903KCumulative $14M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.6M · 2010
Seed extension$2.8M · 2010
Series A$4.3M · 2013
Series A extension$500K · 2013
Series A extension$4.3M · 2016
Series A extension$903K · 2018

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$18.2M
Base estimate est.
$1.2M
Conservative case
$99.1M
Upside case
$4.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $38.4M · 2010-07-302010Seed · modeled $68.8M · 2010-07-30Series A · modeled $86.2M · 2013-01-29Series A · modeled $10.1M · 2013-12-16Series A · modeled $87.0M · 2016-12-21Series A · modeled $18.2M · 2018-11-152018
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
7.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
20 mo
Avg between rounds
$1.5M/yr
Capital velocity
15.9 yr
On record since
2010
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 5.3× above median
This company$12.8M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$903K
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.8× of median
This company$18.2M
Sector median$22.1M

Raised more than 79% of sector peers (real $). Modeled value above 46% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #144 of 157.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)HemoSonics, LLC · Series A Raised $24.9M · modeled $302.7M (est)Airxpanders Inc · Series A Raised $60.0M · modeled $300.5M (est)Mercator Medsystems Inc · Series A Raised $20.5M · modeled $289.2M (est)Simple Contacts Inc. · Series A Raised $24.1M · modeled $285.5M (est)AVG Holdings, Inc. · Series A Raised $14.0M · modeled $282.5M (est)Avia Holdings, Llc · Series A Raised $27.9M · modeled $272.7M (est)Traditions at Rivertown Park, LLC · Series A Raised $13.5M · modeled $272.4M (est)Access Integrated Healthcare, LLC · Series A Raised $13.2M · modeled $265.8M (est)Gauss Surgical, Inc. · Series A Raised $20.5M · modeled $254.2M (est)4WEB, Inc. · Series A Raised $12.5M · modeled $252.2M (est)Iantech, Inc. · Series A Raised $12.2M · modeled $246.7M (est)AbsoluteCARE, Inc. · Series A Raised $25.7M · modeled $242.6M (est)Mardil, Inc. (this company) Raised $12.8M · modeled $18.2M (est)Mardil, Inc.
CompanyStageRaised · realValue · estvs peer med.
HemoSonics, LLCSeries A$24.9M$302.7M2.50×
Airxpanders IncSeries A$60.0M$300.5M2.48×
Mercator Medsystems IncSeries A$20.5M$289.2M2.39×
Simple Contacts Inc.Series A$24.1M$285.5M2.36×
AVG Holdings, Inc.Series A$14.0M$282.5M2.33×
Avia Holdings, LlcSeries A$27.9M$272.7M2.25×
Traditions at Rivertown Park, LLCSeries A$13.5M$272.4M2.25×
Access Integrated Healthcare, LLCSeries A$13.2M$265.8M2.20×
Gauss Surgical, Inc.Series A$20.5M$254.2M2.10×
4WEB, Inc.Series A$12.5M$252.2M2.08×
Iantech, Inc.Series A$12.2M$246.7M2.04×
AbsoluteCARE, Inc.Series A$25.7M$242.6M2.00×
Mardil, Inc. this companySeries A$12.8M$18.2M0.15×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.6M2010-07-30$7.8M$38.4M85%
Seed$2.8M2010-07-30$13.9M$68.8M85%
Series A$4.3M2013-01-29$19.4M$86.2M85%
Series A$500K2013-12-16$2.3M$10.1M85%
Series A$4.3M2016-12-21$19.6M$87.0M90%
Series A$903K2018-11-15$4.1M$18.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.6M2010-07-30
    • First recorded raise — entered as Seed.
    • 2 investors on this round.
  2. Seed$2.8M2010-07-30
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.8× larger than the prior — scaling up.
    • 3 investors on this round.
  3. Series A$4.3M2013-01-29
    • Raised again after 30 mo — slower than the ~14 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 4 investors on this round.
  4. Series A$500K2013-12-16
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 8.5× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 2 investors on this round.
  5. Series A$4.3M2016-12-21
    • Raised again after 36 mo — slower than the ~14 mo sector norm.
    • Round 8.6× larger than the prior — scaling up.
    • 25 investors on this round.
  6. Series A$903K2018-11-15
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 4.8× smaller than the prior — bridge or down round.
    • 7 investors on this round.
Intelligence
2020 ~Q3
Modeled next raise · ~20mo cadence
$903K
Modeled next size est.range $903K$1.4M
0.2×
Last step-up
$1.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Daniel Pelak4 other2010-07
Ramesh Alur2 other2010-07
Gopal Muppirala1 other2010-07
Jaishankar Raman1 other2010-07
JAMES F. BUCK1 other2010-07
JIM BUCK1 other2013-01
Martin Madden1 other2018-11
Aaron Hjelle2018-11
Andy Betts2018-11
DAN ANDREW PELAK2013-01
DANIEL ANDREW PELAK2016-12
Hilary Cheong2018-11
JAMES BUCK2016-12
J. Andrew Betts2010-07
MARSHALL ANDREW STANTON2013-01
Marshall Stanton2018-11
MOHAMED ABDUL NASER ANDREW BIN JAAFAR, MD2016-12
MOHAMED ABDUL NASER ANDREW BIN MD JAAFAR2013-01
WARREN ANDREW WATSON2013-12
Registry & provenance

Mardil, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1498408
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Phoenix Cardiac Devices, Inc.BiotechnologySeries A$7.2M$179.6Mnetwork2 shared operators · same stage
Mednition, Inc.Other Health CareSeries A$13.0M$18.8Msame sector · same stage
Innovein, Inc.Other Health CareSeries A$13.3M$20.5Msame sector · same stage
SMRxT, INC.Other Health CareSeries A$13.3M$20.2Msame sector · same stage
St Cloud Outpatient Surgery LtdOther Health CareSeries A$13.3M$17.2Msame sector · same stage
Xoft IncOther Health CareSeries A$12.1M$16.2Msame sector · same stage
Structural Elements Holdings, LLCOther Health CareSeries A$14.4M$19.1Msame sector · same stage
Pascal Metrics Inc.Other Health CareSeries A$10.9M$20.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Pelvital Usa, Inc.Other Health CareSeed$435K85%
MediCall Inc.Other Health CarePre-Seed$7.3M85%
Pymedix, Inc.Other Health CarePre-Seed$1.4M85%
MetaModix, Inc.Other Health CareSeed$4.2M85%
Carallel, Inc.Other Health CareSeries A$7.9M84%
Carmell CorpOther Health CareSeed$426K83%
Medifoodz, Inc.Other Health CarePre-Seed$374K83%
PharmD Live CorpOther Health CarePre-Seed$11.1M83%
Frequently asked
How much funding has Mardil, Inc. raised?
Mardil, Inc. has raised approximately $12.8M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Mardil, Inc.'s estimated valuation?
Provath's modeled valuation for Mardil, Inc. is approximately $18.2M (modeled range $1.2M–$99.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Mardil, Inc. at?
Mardil, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Nov 15.
What does Mardil, Inc. do and where is it based?
Mardil, Inc. operates in the Other Health Care sector, based in PLYMOUTH.
Explore related

See where Mardil, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Mardil, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.